B. Riley Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$204K Buy
+4,224
New +$181K 0.01% 765
2026
Q1
Sell
-8,048
Closed -$409K 1047
2025
Q4
$409K Sell
8,048
-754
-9% -$38.6K 0.02% 600
2025
Q3
$488K Sell
8,802
-649
-7% -$38K 0.02% 541
2025
Q2
$652K Buy
+9,451
New +$643K 0.03% 446
2024
Q4
$3.16M Sell
36,734
-2,748
-7% -$297K 0.1% 198
2024
Q3
$4.62M Sell
39,482
-20,024
-34% -$2.67M 0.13% 173
2024
Q2
$8.49M Buy
59,506
+5,510
+10% +$730K 0.22% 94
2024
Q1
$4.91M Buy
53,996
+3,219
+6% +$383K 0.13% 159
2023
Q4
$5.25M Sell
50,777
-3,219
-6% -$318K 0.14% 168
2023
Q3
$4.91M Buy
53,996
+9,832
+22% +$866K 0.13% 159
2023
Q2
$3.57M Buy
44,164
+2,990
+7% +$244K 0.08% 240
2023
Q1
$3.3M Sell
41,174
-2,640
-6% -$187K 0.09% 228
2022
Q4
$2.96M Sell
43,814
-4,780
-10% -$280K 0.08% 247
2022
Q3
$2.42M Buy
48,594
+8,914
+22% +$478K 0.07% 267
2022
Q2
$2.21M Buy
39,680
+2,668
+7% +$148K 0.09% 220
2022
Q1
$2.06M Buy
37,012
+26
+0.1% +$1.33K 0.07% 296
2021
Q4
$2.07M Buy
36,986
+1,236
+3% +$67K 0.06% 340
2021
Q3
$1.7M Buy
35,750
+286
+0.8% +$13.8K 0.05% 379
2021
Q2
$1.47M Sell
35,464
-256
-0.7% -$9.92K 0.05% 407
2021
Q1
$1.2M Buy
+35,720
New +$1.27M 0.04% 432
2015
Q1
Sell
-1,832
Closed -$39 1503
2014
Q4
$39 Buy
+1,832
New +$40.9K ﹤0.01% 2224
2014
Q3
Sell
-2,092
Closed -$48.3K 1463
2014
Q2
$48.3K Buy
+2,092
New +$46.2K 0.01% 1046

Other funds holding NVO

B. Riley Wealth Advisors's NVO Position: Q2 2026 in Review

B. Riley Wealth Advisors opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,224 shares worth $204K. The stake represents 0.01% of the portfolio and ranks #765 among its holdings. This is a return to the name: B. Riley Wealth Advisors previously reported a position in NVO as recently as Q4 2025.

B. Riley Wealth Advisors first reported a position in NVO in Q2 2014 and has held it in 22 quarters since. The position peaked at $8.49M in Q2 2024. 240 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • B. Riley Wealth Advisors held 4,224 shares of Novo Nordisk worth $204K as of Q2 2026.
  • Novo Nordisk was a new B. Riley Wealth Advisors position in Q2 2026.
  • Novo Nordisk made up 0.01% of B. Riley Wealth Advisors's portfolio in Q2 2026, its #765 holding.
  • B. Riley Wealth Advisors first reported a position in Novo Nordisk in Q2 2014 and has held it in 22 quarters since.
  • B. Riley Wealth Advisors's Novo Nordisk position peaked at $8.49M in Q2 2024.
  • 240 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.